
1. j neurovirol. 2005;11 suppl 3:52-7.

new features progressive multifocal leukoencephalopathy era highly
active antiretroviral therapy natalizumab.

lima ma(1), koralnik ij.

author information: 
(1)department neurology, beth israel deaconess medical center, harvard medical
school, boston, 02215, usa.

over past three decades, progressive multifocal leukoencephalopathy (pml)
evolved clinical rarity become important cause neurological
complications acquired immunodeficiency syndrome (aids) patients. recently
this disease unexpectedly occurred patients receiving novel
immunomodulatory medication natalizumab. changes epidemiology pml
also brought new questions regard pathogenesis disease. the
authors review current challenges diagnosis management patients
with pml, based recent advances understanding jc virus
biology discuss potential methods monitor disease evolution predict
outcome.

doi: 10.1080/13550280500513325 
pmid: 16540456  [indexed medline]

